Stopped early
VIT-ARMin Virtual, Intensified and Patient-tailored Robotic Arm Therapy With the Exoskeleton Robot ARMin
NCT02720341 · Swiss Federal Institute of Technology · Updated 9 Oct 2020
- What is being tested
- ARMin
- For
- Stroke; Spinal Cord Injury; Healthy
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 222 people. The full rules are on the registry page.
- Where
- Switzerland (3 sites)
- When
- Starts or started 10 April 2015, ends July 2020. Registered 25 March 2016.
- Results
- None posted yet.
In the researchers' words
Consideration-of-Concept Trial (stage 1) on robotic therapy of the upper extremity with the ARMin therapy robot in healthy subjects and patients with neurological disease (e.g. stroke, spinal cord injury)
Sites
- Labor für Sensomotorische Systeme, ETH Zürich, Balgrist CampusZurich, Switzerland
- Balgrist CampusZurich, Switzerland
- Klinik LenggZurich, Switzerland